MiR-429 increases the metastatic capability of HCC via regulating classic Wnt pathway rather than epithelial-mesenchymal transition

Cancer Letters

Volumn 364, Issue 1, 2015, Pages 33-43

  Tang, Jing ^a,b   Li, Liang ^a,b   Huang, Wentao ^a,c   Sui, Chengjun ^b   Yang, Yingcheng ^a   Lin, Ximeng ^a   Hou, Guojun ^a   Chen, Xin ^a   Fu, Jing ^a   Yuan, Shengxian ^b   Li, Shao ^d   Wen, Wen ^a   Tang, Shanhua ^a   Cao, Dan ^a   Wu, Mengchao ^a,b   Chen, Lei ^a,b   Wang, Hongyang ^a,b,e  

^a National Scientific Centre for Liver Cancer   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c FUJIAN MEDICAL UNIVERSITY   (China)

^d TSINGHUA UNIVERSITY   (China)

^e SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Metastasis; MicoRNA 429; PTEN

Indexed keywords

BETA CATENIN; MICRORNA; MICRORNA 429; PHOSPHATIDYLINOSITOL 3 KINASE; UNCLASSIFIED DRUG; MIRN429 MICRORNA, HUMAN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PTEN PROTEIN, HUMAN; WNT PROTEIN;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL; CANCER PROGNOSIS; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CPG ISLAND; DNA METHYLATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE LOCATION; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; PTEN GENE; RECURRENCE FREE SURVIVAL; TUMOR INVASION; TUMOR SUPPRESSOR GENE; UPREGULATION; GENETICS; LIVER TUMOR; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; LIVER NEOPLASMS; MICRORNAS; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; PTEN PHOSPHOHYDROLASE; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 84929653617     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.04.023     Document Type: Article

References (30)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin 2011, 61(2):69-90.
2. He J., Gu D., Wu X., Reynolds K., Duan X., Yao C., et al. Major causes of death among men and women in China. NEJM 2005, 353(11):1124-1134.
3. He L., Thomson J.M., Hemann M.T., Hernando-Monge E., Mu D., Goodson S., et al. A microRNA polycistron as a potential human oncogene. Nature 2005, 435(7043):828-833.
4. Mraz M., Mraz M., Pospisilova S., Malinova K., Slapak I., Mayer J. MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes. Leuk. Lymphoma 2009, 50(3):506-509.
5. Gramantieri L., Fornari F., Callegari E., Sabbioni S., Lanza G., Croce C.M., et al. MicroRNA involvement in hepatocellular carcinoma. J. Cell. Mol. Med 2008, 12(6a):2189-2204.
6. Garzon R., Calin G.A., Croce C.M. MicroRNAs in cancer. Annu. Rev. Med 2009, 60:167-179.
7. Iorio M.V., Croce C.M. MicroRNAs in cancer: small molecules with a huge impact. J. Clin. Oncol 2009, 27(34):5848-5856.
8. Peter M.E. Let-7 and miR-200 microRNAs. Cell Cycle 2009, 8(6):843-852.
9. Burk U., Schubert J., Wellner U., Schmalhofer O., Vincan E., Spaderna S., et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 2008, 9(6):582-589.
10. Korpal M., Lee E.S., Hu G., Kang Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem 2008, 283(22):14910-14914.
11. Gregory P.A., Bert A.G., Paterson E.L., Barry S.C., Tsykin A., Farshid G., et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol 2008, 10(5):593-601.
12. Park S.M., Gaur A.B., Lengyel E., Peter M.E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 2008, 22(7):894-907.
13. Li L., Tang J., Zhang B., Yang W., LiuGao M., Wang R., et al. Epigenetic modification of MiR-429 promotes liver tumour-initiating cell properties by targeting Rb binding protein 4. Gut 2015, 64(1):156-167.
14. Wang T., Hu H.S., Feng Y.X., Shi J., Li N., Guo W.X., et al. Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma. Br. J. Cancer 2010, 102(11):1618-1626.
15. Li L., Chen L., Hu L., Liu Y., Sun H.Y., Tang J., et al. Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice. Hepatology 2011, 54(5):1620-1630.
16. Le M.T., Hamar P., Guo C., Basar E., Perdigao-Henriques R., Balaj L., et al. miR-200-containing extracellular vesicles promote breast cancer cell metastasis. J. Clin. Invest 2014, 124(12):5109-5128.
17. Lewis B.P., Shih I.H., Jones-Rhoades M.W., Bartel D.P., Burge C.B. Prediction of mammalian microRNA targets. Cell 2003, 115(7):787-798.
18. Kanehisa M., Goto S., Furumichi M., Tanabe M., Hirakawa M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 2010, 38(Database issue):D355-D360.
19. Wu X., Jiang R., Zhang M.Q., Li S. Network-based global inference of human disease genes. Mol. Syst. Biol 2008, 4:189.
20. Wan X.W., Jiang M., Cao H.F., He Y.Q., Liu S.Q., Qiu X.H., et al. The alteration of PTEN tumor suppressor expression and its association with the histopathological features of human primary hepatocellular carcinoma. J. Cancer Res. Clin. Oncol 2003, 129(2):100-106.
21. Huang W., Chang H.Y., Fei T., Wu H., Chen Y.G. GSK3 beta mediates suppression of cyclin D2 expression by tumor suppressor PTEN. Oncogene 2007, 26(17):2471-2482.
22. Uka K., Aikata H., Takaki S., Shirakawa H., Jeong S.C., Yamashina K., et al. Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma. World J. Gastroenterol 2007, 13(3):414-420.
23. Horie Y., Suzuki A., Kataoka E., Sasaki T., Hamada K., Sasaki J., et al. Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J. Clin. Invest 2004, 113(12):1774-1783.
24. Sumazin P., Yang X., Chiu H.S., Chung W.J., Iyer A., Llobet-Navas D., et al. An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma. Cell 2011, 147(2):370-381.
25. Tay Y., Kats L., Salmena L., Weiss D., Tan S.M., Ala U., et al. Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 2011, 147(2):344-357.
26. Kato M., Putta S., Wang M., Yuan H., Lanting L., Nair I., et al. TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat. Cell Biol 2009, 11(7):881-889.
27. Xiao C., Srinivasan L., Calado D.P., Patterson H.C., Zhang B., Wang J., et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol 2008, 9(4):405-414.
28. Hur K., Toiyama Y., Takahashi M., Balaguer F., Nagasaka T., Koike J., et al. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. Gut 2013, 62(9):1315-1326.
29. Cochrane D.R., Howe E.N., Spoelstra N.S., Richer J.K. Loss of miR-200c: a marker of aggressiveness and chemoresistance in female reproductive cancers. J. Oncol 2010, 2010:821717.
30. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136(2):215-233.